Li, Xiaoxia
Cleveland Clinic Foundation,
United States
2025 Rank: 36729
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 704 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36729 | 39725 |
| Total Cites | 1598 | 1665 |
| H-index | 16 | 17 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 119 | 124 |
| Number of Single+First+Last Authored Papers | 114 | 114 |
| Total Cites to Single+First+Last Authored Papers | 685 | 711 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1407 | 1443 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.15 |
| Self-Citation Percentage |
4.02%
|
|
Li, Xiaoxia
Cleveland Clinic Foundation,
United States
2024 Rank: 33002
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 697 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33002 | 34533 |
| Total Cites | 1769 | 1854 |
| H-index | 19 | 20 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 99 | 102 |
| Number of Single+First+Last Authored Papers | 113 | 113 |
| Total Cites to Single+First+Last Authored Papers | 738 | 757 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1455 | 1501 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.24 |
| Self-Citation Percentage |
4.58%
|
|
Li, Xiaoxia
Cleveland Clinic Foundation,
United States
2023 Rank: 27394
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 634 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27394 | 30019 |
| Total Cites | 1936 | 2026 |
| H-index | 21 | 21 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 113 | 117 |
| Number of Single+First+Last Authored Papers | 111 | 111 |
| Total Cites to Single+First+Last Authored Papers | 838 | 880 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1576 | 1615 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.25 |
| Self-Citation Percentage |
4.44%
|
|
Li, Xiaoxia
Cleveland Clinic Foundation,
United States
2022 Rank: 30733
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 829 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 30733 | 33605 |
| Total Cites | 1714 | 1817 |
| H-index | 19 | 20 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 85 | 90 |
| Number of Single+First+Last Authored Papers | 108 | 108 |
| Total Cites to Single+First+Last Authored Papers | 686 | 710 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1407 | 1468 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.24 |
| Self-Citation Percentage |
5.67%
|
|
Li, Xiaoxia
Cleveland Clinic Foundation,
United States
2021 Rank: 36587
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 893 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36587 | 37824 |
| Total Cites | 2474 | 2634 |
| H-index | 23 | 24 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 6 | 7 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 97 | 103 |
| Number of Single+First+Last Authored Papers | 107 | 107 |
| Total Cites to Single+First+Last Authored Papers | 958 | 1028 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1985 | 2055 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.28 |
| Self-Citation Percentage |
6.07%
|
|
Li, Xiaoxia
Cleveland Clinic Foundation,
United States
2020 Rank: 46628
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1008 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46628 | 44787 |
| Total Cites | 1736 | 1896 |
| H-index | 18 | 20 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 7 | 8 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 44 | 46 |
| Number of Single+First+Last Authored Papers | 101 | 101 |
| Total Cites to Single+First+Last Authored Papers | 620 | 685 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1403 | 1467 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.29 |
| Self-Citation Percentage |
8.44%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.